drugset / Trial / NCT01291563

TMC207TBC1003 - A Study in Healthy Volunteers Investigating the Effect of Single-dose TMC207 on the QT/QTc Interval Under Fed Conditions

NCT01291563

Phase 1 Completed 88 enrolled Tibotec BVBA
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of an 800-mg single dose of TMC207 on the QT/QTc interval in healthy volunteers.

Timeline

Start
2011-02
Primary completion
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Bedaquiline Small molecule 100 mg
Comparator Moxifloxacin Small molecule 400 mg

Indications

No indication recorded.